Valneva CEO on Pfizer-partnered Lyme vaccine: Why a phase 3 miss doesn’t tell the whole story - Fierce Biotech
In the world of clinical trials, missing the primary endpoint of a pivotal trial typically spells real trouble for a drug program. | In the world of clinical trials, missing the primary endpoint of a pivotal trial typically spells real trouble for a drug prog…
Comments